Balyasny Asset Management
SEM

Balyasny Asset Management’s Select Medical SEM Stock Holding History

Balyasny Asset Management’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-278,400
Closed -$2.25M – 1452
2020
Q1 		$2.25M Buy
+278,400
New +$3.31M 0.03% 598

Other funds holding SEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Balyasny Asset Management's SEM Position: Q1 2026 in Review

Balyasny Asset Management increased its Select Medical (SEM) stake by 1,502% in Q1 2026, buying an estimated $13.3M and bringing the position to 904,737 shares worth $14.7M. The position accounts for 0.02% of the portfolio, ranked #829.

Balyasny Asset Management first reported a position in SEM in Q3 2015 and has held it in 17 quarters since. 277 funds tracked by Wall St. Rank hold SEM as of Q1 2026.

  • Balyasny Asset Management held 904,737 shares of Select Medical worth $14.7M as of Q1 2026.
  • Balyasny Asset Management bought 848,246 Select Medical shares in Q1 2026, an estimated $13.3M.
  • Select Medical made up 0.02% of Balyasny Asset Management's portfolio in Q1 2026, its #829 holding.
  • Balyasny Asset Management first reported a position in Select Medical in Q3 2015 and has held it in 17 quarters since.
  • 277 funds tracked by Wall St. Rank held Select Medical as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.